Case Report: Immune Checkpoint Inhibitor-Induced Exuberant Tumor Inflammation With Accelerated Clinical Deterioration in Metastatic Renal Cell Carcinoma

Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy. Nivolumab, an anti-PD-1 monoclonal antibody, markedly improved overall survival in advanced renal cell carcinoma (RCC). However, ICIs can rarely trigger massive inflammation, a phenomenon characterized by rapid acceleration in r...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Oncol
Main Authors: Gopalakrishnan, Dharmesh, Jain, Rohit K., Herbst, Laurie, Sikorski, Marcus, Mandava, Silpa, Azabdaftari, Gissou, Xu, Bo, LeVea, Charles, Robillard, Kevin, Ernstoff, Marc S., George, Saby
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2021
Assuntos:
Oncology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8117341/
https://ncbi.nlm.nih.gov/pubmed/33996609
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.679177
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares